Physician profile
Patrick S Buckley
NPI 1427315969
$36,940.61
in general payments reported to CMS, 2019-2025
13 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $79.61 · 2021: $203 · 2022: $3,259 · 2023: $284 · 2024: $12K · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Consulting Fee: $3,806 · Food and Beverage: $1,006 · Travel and Lodging: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Consulting Fee | $3,806.25 |
| Food and Beverage | $1,006.12 |
| Travel and Lodging | $933.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,061.00 | 2019 | |
| Smith+Nephew, INC. | $15,094.89 | 2019-2025 | Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium, Rf20000 |
| Integra Lifesciences Corporation | $165.25 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Dynasplint Systems INC. | $121.71 | 2021 | |
| Avanos Medical | $113.80 | 2022-2024 | On-Q* Pump and Accessories |
| Zimmer Biomet Holdings, INC. | $95.21 | 2023-2024 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $84.44 | 2019-2025 | Monovisc, Orthovisc |
| Miach Orthopaedics, INC. | $67.31 | 2021 | |
| Stryker Corporation | $57.14 | 2024 | Gamma |
| Globus Medical, INC. | $31.06 | 2024 | Proximal Humerus Strut, Distal Radius II, Mini Fragment System |
| Linvatec Corporation | $18.44 | 2023 | Biobrace 23mm |
| Vertex Pharmaceuticals Incorporated | $15.42 | 2025 | |
| Vericel Corporation | $14.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.